NCT07049120View on ClinicalTrials.gov

Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions

NANot yet recruitingINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

October 31, 2027

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

ZENFLEX Pro™ Peripheral Drug-eluting Stent System

The ZENFLEX Pro™ Peripheral Drug-eluting Stent System will be implanted in patients with femoropopliteal artery lesions to evaluate safety and efficacy outcomes. The device is designed to provide mechanical support and deliver antiproliferative drug locally to reduce restenosis. The procedure will be performed via standard endovascular techniques.

Trial Locations (1)

32-500

American Heart of Poland, Małopolskie Cardiovascular Center PAKS Chrzanów, Chrzanów

All Listed Sponsors
lead

Zhejiang Zylox Medical Device Co., Ltd.

INDUSTRY